Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's Pre-Market Session

Author: Benzinga Insights | December 28, 2020 09:29am

 

Gainers

  • Ocugen (NASDAQ:OCGN) shares rose 43.74% to $2.53 during Monday's pre-market session. The market value of their outstanding shares is at $409.9 million.
  • Osmotica Pharmaceuticals (NASDAQ:OSMT) shares rose 21.67% to $6.23. The company's market cap stands at $389.9 million.
  • Myovant Sciences (NYSE:MYOV) stock rose 19.12% to $27.1. The company's market cap stands at $2.4 billion.
  • Bionano Genomics (NASDAQ:BNGO) shares rose 16.32% to $0.82. The company's market cap stands at $125.6 million.
  • Jaguar Health (NASDAQ:JAGX) stock moved upwards by 16.08% to $0.83. The company's market cap stands at $78.7 million.
  • IMV (NASDAQ:IMV) shares increased by 11.14% to $3.39. The market value of their outstanding shares is at $227.4 million.

 

 

Losers

 

  • Addex Therapeutics (NASDAQ:ADXN) shares declined by 29.73% to $17.0 during Monday's pre-market session. The market value of their outstanding shares is at $75.1 million.
  • MediciNova (NASDAQ:MNOV) shares fell 9.77% to $5.08. The company's market cap stands at $228.2 million.
  • Miragen Therapeutics (NASDAQ:MGEN) stock fell 6.98% to $16.4. The market value of their outstanding shares is at $64.0 million.
  • Pharming (NASDAQ:PHAR) stock decreased by 5.07% to $14.8.
  • Anchiano Therapeutics (NASDAQ:ANCN) stock fell 4.98% to $2.1. The company's market cap stands at $15.5 million.
  • Neos Therapeutics (NASDAQ:NEOS) shares decreased by 4.75% to $0.65. The company's market cap stands at $32.4 million.

 

 

Posted In: ADXN ANCN BNGO IMV JAGX MGEN MNOV MYOV NEOS OCGN OSMT PHAR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist